Thursday, 20 February 2020

Japan News

  • Daiichi Sankyo reveals its five-year business plan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2013

    Singapore: Daiichi Sankyo has announced a new five-year business plan, which will span from April 1, 2013 through March 31, 2018. As part of the new plan, the company said it will work towa...Read more

  • Daiichi to work with US FDA to solve Ranbaxy quality issue

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2013

    Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the company's majority stakeholder, Daiichi Sankyo, has now made a state...Read more

  • Takeda gets go ahead for teduglutide in Europe

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: The European Commission (EC) has granted European market authorization for the medicinal product teduglutide (Revestive in Europe) as a once-daily treatment for adult patients wi...Read more

  • Astellas, UMN pharma to curb influenza in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2014

    Singapore: In a bid to curtail the growing cases of influenza in Japan, Astellas announced that it has submitted an application for marketing approval of recombinant influenza HA vaccine A...Read more

  • Big Pharma continues acquisitions

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month for M&A activity, with companies making transactions for more th...Read more

  • Ranbaxy aiming to sell its generics in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Nov, 2013

    Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma company, Daiichi Sankyo has planned to supply medicines in Japan fro...Read more

  • Daiichi Sankyo and Asubio merge to streamline operations

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2015

    Daiichi Sankyo Inc., the US subsidiary of Daiichi Sankyo Company Ltd, will merge with its US-based sister company, Asubio Pharmaceuticals Inc. As a result, Asubio Pharmaceuticals, Inc. proj...Read more

  • What functional roles do CROs play in APAC?

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Astellas joins hands with Tecnofarma International

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2013

    Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecnofarma International to distribute enzalutamide (trade name Xtandi in ...Read more

  • BSA-CMR Survey: New CRO players emerge in APAC

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Alchemia gets US patent for oncology platform technology

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2013

    Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to its platform oncology technology. The patent is being regarded as a ...Read more

  • Japan to develop vaccine for H7N9 bird flu

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: A panel of experts at the Health, Labor and Welfare Ministry of Japan will start producing a vaccine for the H7N9 strain of avian influenza, according to a report published by Th...Read more

  • Kitasato Daiichi Sankyo to shut animal vaccine unit

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Singapore: Daiichi Sankyo's animal vaccine unit, Kitasato Daiichi Sankyo Vaccine is discontinuing its animal vaccine business at the end of FY2013 in order to focus resources on vaccines fo...Read more

  • OptiMedica expands footprint in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2012

    Singapore: Global ophthalmic company OptiMedica has expanded international market adoption of its Catalys Precision Laser System with new installations at the premier Shinagawa LASIK Cente...Read more

  • WaferGen, Qiagen sign Next-Gen sequencing deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

    Singapore: WaferGen Bio-systems announced a co-marketing agreement with Qiagen for the promotion of certain products in Japan in the areas of genomics platforms such as Next-Gen sequencing ...Read more

  • Novartis's Ultibro Breezhaler receives EC, Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2013

    Singapore: Novartis has announced that the European Commission has approved once-daily Ultibro Breezhaler (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatm...Read more

  • Shimadzu India aims at 15-20% growth

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connecting with their customers through various initiatives. Recently, it orga...Read more

  • Ex-GSK boss promoted as Takeda's CEO

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Japan's Takeda Pharmaceutical has promoted Mr Christophe Weber, representative director, president and chief operating Officer (COO), as the chief executive officer (CEO) of the ...Read more